Xcout Intel
Dignify Therapeutics, LLC
Dignify Therapeutics is a biotechnology company located in Research Triangle Park, North Carolina. The company focuses on developing pharmaceutical solutions to bolster bowel and bladder control for patients.
Subscribe to see Dignify Therapeutics, LLC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Dignify Therapeutics, LLC at a glance
Dignify Therapeutics, LLC is a pharmaceuticals company headquartered in United States, founded in 2013. It has raised at least $1.6M across the 2 funding rounds on record. Its most recent funding round raised $800,000 in September 2026. Xcout tracks 17 named people at Dignify Therapeutics, LLC, including Anthony DiTonno (CEO).
Dignify Therapeutics, LLC leadership
- Anthony DiTonnoCEO
- Benny WardCEO
- Ed Burgard, Ph.D.President
- Jeff WelchChief Operating Officer
- Karl Thor, Ph.D.Chief Scientific Officer
- Dan Ricca, Ph.D.VP of Chemistry
11 more named people on record for Dignify Therapeutics, LLC, with roles, board committees and tenure — see the full roster →
Dignify Therapeutics, LLC funding rounds
At least $1.6M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $800,000 | — | |
| Grant | $800,000 | 4 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Dignify Therapeutics, LLC competitors
A few of Dignify Therapeutics, LLC's closest competitors — see the full list of competitors and alternatives →
Incyclix Bio is an oncology therapeutics company headquartered in Research Triangle Park, North Carolina. Founded by pioneers in CDK inhibitor discovery, research, and development, the company focuses on creating innovative cancer treatments.
RDD Pharma Ltd. is a biopharmaceutical company focused on the discovery and development of therapeutic products for gastrointestinal and anorectal diseases. Headquartered in Israel with locations in Tel Aviv and Ofakim, the company specializes in targeted treatments.
Emergo Therapeutics, Inc. is a biopharmaceutical holding company and startup headquartered in Durham, North Carolina, focused on drug pipelines and the production of inflammatory cytokines.
LifeWell is a pharmaceutical company founded in Portugal in 2016 that researches, develops, and commercializes innovative therapeutic solutions in gynecology, obstetrics, fertility, and urology.
Slate Medicines is a privately held biotechnology company advancing next-generation therapeutics for headache treatment, with headquarters located in Raleigh, North Carolina and Boston, Massachusetts.
Dicot Pharma is a pharmaceutical company that develops new potency drugs targeting sexual dysfunctions in men. Its primary drug candidate, LIB-01, is designed to treat erectile dysfunction with a prolonged duration of action. The company serves patients and healthcare markets by focusing on next-generation treatments to improve quality of life.
Get Dignify Therapeutics, LLC's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Dignify Therapeutics, LLC in Xcout Intel
- 17 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access